☰ Navigation Tabs
Latent-state naloxone-mu opioid receptor-Gi GDPbS complex (rebound)
Refinement RMS Deviations Key Refinement Restraint Deviation f_dihedral_angle_d 5.43 f_angle_d 0.673 f_chiral_restr 0.048 f_bond_d 0.004 f_plane_restr 0.004
Sample Naloxone-mu opioid receptor in complex in complex with Gai-GDPbS, Gb1 and Gg2
Specimen Preparation Sample Aggregation State PARTICLE Vitrification Instrument FEI VITROBOT MARK IV Cryogen Name ETHANE Sample Vitrification Details
3D Reconstruction Reconstruction Method SINGLE PARTICLE Number of Particles 111366 Reported Resolution (Å) 3.8 Resolution Method FSC 0.143 CUT-OFF Other Details Refinement Type Symmetry Type POINT
Map-Model Fitting and Refinement Id 1 Refinement Space Refinement Protocol Refinement Target Overall B Value Fitting Procedure Details
Data Acquisition Detector Type GATAN K3 BIOQUANTUM (6k x 4k) Electron Dose (electrons/Å**2) 51
Imaging Experiment 1 Date of Experiment Temperature (Kelvin) Microscope Model TFS KRIOS Minimum Defocus (nm) 1500 Maximum Defocus (nm) 2500 Minimum Tilt Angle (degrees) Maximum Tilt Angle (degrees) Nominal CS Imaging Mode BRIGHT FIELD Specimen Holder Model FEI TITAN KRIOS AUTOGRID HOLDER Nominal Magnification Calibrated Magnification Source FIELD EMISSION GUN Acceleration Voltage (kV) 300 Imaging Details
EM Software Task Software Package Version PARTICLE SELECTION cryoSPARC IMAGE ACQUISITION EPU 2 CTF CORRECTION cryoSPARC v4.3.1 INITIAL EULER ASSIGNMENT cryoSPARC v4.3.1 FINAL EULER ASSIGNMENT cryoSPARC v4.3.1 CLASSIFICATION cryoSPARC v4.3.1 RECONSTRUCTION cryoSPARC v4.3.1
Image Processing CTF Correction Type CTF Correction Details Number of Particles Selected Particle Selection Details PHASE FLIPPING AND AMPLITUDE CORRECTION